you are here: Home News Pharmaceutical

Pharmaceutical

Cipla stock crashes over 3% as brokerages cut targets on Lanreotide disruption, FY27 risks
Chart of the Day: Weight loss drugs to give fillip to Indian pharma market in 2026
Cough syrup-related deaths: Pharma factory in Tamil Nadu probed after 9 children die from consuming 'Coldrif' in MP
Trump's 100% tariff on branded drugs: Exporters assessing impact on complex generics
FTAs are welcome but don’t let them undermine pharma industry and drug access
Pharma stocks rise up to 4% after better-than-expected Trump order on lower drug prices
Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations
ICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India
Sun Pharma Q1 Results: Net profit jumps 40% on-year to Rs 2,836 crore, beats estimates
Cipla Q1 Results: Net profit rises to Rs 1,178 crore, beats estimate
Steady US sales to bring a healthy quarter for pharma sector
Indian pharmaceutical market registers 9.5% growth in March
Essential medicines to be slightly costlier from April 1
Why government is cracking down on junkets, gifts for doctors by pharma firms
Will a new pharmaceutical marketing code succeed where earlier attempts failed?
Sun Pharma to acquire 16.33% stake of Surgimatix for $3.05 million
JB Pharma Q2 results: Net Profit up 35% to Rs 150.5 crore
Low expectations ahead of September quarter earnings
Aurobindo Pharma’s Telangana plant classified as VAI by US FDA
Lupin Q1 results: Net profit at Rs 453.33 crore from year-ago loss, tops Street estimates
Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
Sun Pharma Q1 PAT seen up 8.6% YoY to Rs 2,238.8 cr: Nirmal Bang
Natco Q1 PAT seen up 36.2% YoY to Rs 436.5 cr: Nirmal Bang
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Pharmaceutical

Cipla stock crashes over 3% as brokerages cut targets on Lanreotide disruption, FY27 risks

Chart of the Day: Weight loss drugs to give fillip to Indian pharma market in 2026

Cough syrup-related deaths: Pharma factory in Tamil Nadu probed after 9 children die from consuming 'Coldrif' in MP

Trump's 100% tariff on branded drugs: Exporters assessing impact on complex generics

FTAs are welcome but don’t let them undermine pharma industry and drug access

Pharma stocks rise up to 4% after better-than-expected Trump order on lower drug prices

Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations

ICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India

Sun Pharma Q1 Results: Net profit jumps 40% on-year to Rs 2,836 crore, beats estimates

Cipla Q1 Results: Net profit rises to Rs 1,178 crore, beats estimate

Steady US sales to bring a healthy quarter for pharma sector

Indian pharmaceutical market registers 9.5% growth in March

Essential medicines to be slightly costlier from April 1

Why government is cracking down on junkets, gifts for doctors by pharma firms

Will a new pharmaceutical marketing code succeed where earlier attempts failed?

Sun Pharma to acquire 16.33% stake of Surgimatix for $3.05 million

JB Pharma Q2 results: Net Profit up 35% to Rs 150.5 crore

Low expectations ahead of September quarter earnings

Aurobindo Pharma’s Telangana plant classified as VAI by US FDA

Lupin Q1 results: Net profit at Rs 453.33 crore from year-ago loss, tops Street estimates

Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang

Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang

Sun Pharma Q1 PAT seen up 8.6% YoY to Rs 2,238.8 cr: Nirmal Bang

Natco Q1 PAT seen up 36.2% YoY to Rs 436.5 cr: Nirmal Bang

Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang